# REXTOVY
> **NDA208969** · New Drug Application · Sponsor: AMPHASTAR PHARMS INC · Approved 2023-03-07
## Drug
- **FDA Application Number:** NDA208969
- **Application type:** New Drug Application
- **Brand name:** REXTOVY
- **Generic name:** NALOXONE HYDROCHLORIDE
- **Active ingredients:** NALOXONE HYDROCHLORIDE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** AMPHASTAR PHARMS INC
- **Manufacturer:** International Medication Systems, Ltd.
- **First approval:** 2023-03-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208969)
---
*MORVS · CC0 1.0*